Sanmedicare Pharma Private Limited
About Sanmedicare Pharma Private Limited
Data last updated:
Sanmedicare Pharma Private Limited is a private limited company based in Gorakhpur, Uttar Pradesh, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 10 September 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U85191UP2014PTC065997.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Shila Choudhary and Ashish Ranjan.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Behind Khetan Petrol Pump Mohaddipur Kunraghat, Gorakhpur, Uttar Pradesh, India – 273001.
As per the financials filed for FY 2019, the company reported a revenue of ₹13.36 Lakh, a growth of 39% compared to the previous year. For the same year it recorded a net profit of ₹8,116 (net margin 0.6%) and EBITDA of ₹8,116 (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sanmedicare Pharma Private Limited's registered office is in Gorakhpur, Uttar Pradesh.
- Registered AddressBehind Khetan Petrol Pump Mohaddipur Kunraghat, Gorakhpur, Uttar Pradesh, India – 273001
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sanmedicare Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sanmedicare Pharma Private Limited, buy the company report.
Financials of Sanmedicare Pharma Private Limited
FY 2021 filings availableSanmedicare Pharma Private Limited reported revenue of ₹13.36 Lakh (up 39% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 5% over three years, including 39% growth in the latest year. EBITDA rose 163% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8,116 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8,116 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.6% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sanmedicare Pharma Private Limited, buy the company report.
Board of directors of Sanmedicare Pharma Private Limited
Sanmedicare Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shila Choudhary | Director | 10 Sep 2014 | 12 Years 1 Months | Current |
| Ashish Ranjan Also directs: Seven Sages Innovations Private Limited | Director | 30 Dec 2015 | 10 Years 9 Months | Current |
| Navita Kumari Also directs: Euzoe Pharma (OPC) Private Limited | Director | 10 Sep 2014 | 12 Years 1 Months | Current |
Peer comparison
Sanmedicare Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Thirumoolar International Siddha Medical Research Foundation | ₹13.39 Lakh (FY 2024) | Chennai, Tamil Nadu, India | ||||
| Arobel International (OPC) Private Limited | ₹13.39 Lakh (FY 2025) | -58.0% | Chavakkad, Kerala, India | |||
| Enlocare Chemicals Private Limited | ₹13.39 Lakh (FY 2025) | 1.0% | Kasargod, Kerala, India | |||
| Augment Pharmaceutical Private Limited | ₹13.38 Lakh (FY 2024) | 2.0% | Japiur, Rajasthan, India | |||
| Saprac Pharmaceutical Private Limited | ₹13.37 Lakh (FY 2024) | Delhi, India | ||||
| Sanmedicare Pharma Private Limitedthis company | ₹13.36 Lakh (FY 2019) | ₹8,116 | 0.6% | 39.0% | Gorakhpur, Uttar Pradesh, India | |
| Satvah Surfactants Private Limited | ₹13.36 Lakh (FY 2024) | -84.0% | Ahmedabad, Gujarat, India | |||
| Westmid Industries Private Limited | ₹13.35 Lakh (FY 2025) | Belda, West Bengal, India | ||||
| Venuschem Laboratories Private Limited | ₹13.34 Lakh (FY 2024) | 440.0% | Navi Mumbai, Maharashtra, India | |||
| Thampuratty's India Private Limited | ₹13.33 Lakh (FY 2022) | 262.0% | New Delhi, Delhi, India | |||
| Mothers Man Pharma Private Limited | ₹13.31 Lakh (FY 2022) | Cachar, Assam, India |
To see the full peer comparison of Sanmedicare Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sanmedicare Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sanmedicare Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sanmedicare Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sanmedicare Pharma Private Limited has 5 board changes on record since 2014: 4 appointments and 1 cessation. The latest: Ashish Ranjan was appointed as Director on 30 Dec 2015.
Frequently asked questions
Sanmedicare Pharma is an active private limited company based in Gorakhpur, Uttar Pradesh, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 10 September 2014 (12+ years old) and is registered under CIN U85191UP2014PTC065997.
Sanmedicare Pharma has 3 current directors:
- Shila Choudhary - Director
- Ashish Ranjan - Director
- Navita Kumari - Director
The latest financial statements of Sanmedicare Pharma on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Sanmedicare Pharma is U85191UP2014PTC065997. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sanmedicare Pharma was incorporated on 10 September 2014, making it 12+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Sanmedicare Pharma by revenue are Thirumoolar International Siddha Medical Research Foundation, Arobel International (OPC) Private Limited, Enlocare Chemicals Private Limited, Augment Pharmaceutical Private Limited, Saprac Pharmaceutical Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ashish Ranjan was appointed as Director on 30 Dec 2015. Apoorva Choudhary ceased to be Director on 10 Jan 2015. Apoorva Choudhary was appointed as Director on 10 Sep 2014. Sanmedicare Pharma has 5 board changes on record in total.
The registered office of Sanmedicare Pharma is at Behind Khetan Petrol Pump Mohaddipur Kunraghat, Gorakhpur, Uttar Pradesh, India – 273001.
Sanmedicare Pharma operates in the chemicals industry, in the medicinal chemical and botanical products segment.
The compliance status of Sanmedicare Pharma is compliant as of 31 July 2026. The company is actively filing with the Registrar of Companies.
Sanmedicare Pharma can be reached at its registered office: Behind Khetan Petrol Pump Mohaddipur Kunraghat, Gorakhpur, Uttar Pradesh, India – 273001.